Option chain shows key data for Lexaria Bioscience's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lexaria Bioscience.

Lexaria Bioscience (NASDAQ:LEXX) Stock, Option Chain

Lexaria Bioscience

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Movers

News

Pre-Market Outlook

Markets

Trading Ideas

ALBT

ANNX

BARK

CAPT

Core Scientific, Inc. - Class A Common Stock

CORZ

FGEN

LEXX

MBOT

MLGO

NIVF

PLTN

SQNS

WIMI

YGMZ

Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

ACAD

AEVA

ASAN

ASRT

BCAN

BLDE

The Beachbody Company, Inc. Class A Common Stock

BODI

BWMN

CLRO

CRBU

CTMX

DTSS

ENPH

ESGL

FNCH

GERN

GOEV

HRTG

IONM

JANX

JFBR

KITT

LGCL

LICY

MNSO

NRXP

NUKK

OCUL

ONON

ORCL

PACK

PRST

RERE

RGLS

RNLX

SGLY

SMXT

SPPL

TALK

VINC

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Lexaria Bioscience shares are trading lower by 6.5% Thursday morning. The company finalized agreements for a registered direct offering.

Why Lexaria Bioscience (LEXX) Shares Are Moving

Lexaria Bioscience Corp

UBS analyst Colin Bristow maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Neutral and raises the price target from $70 to $96.

Price Target

Analyst Ratings

GILD

UBS Maintains Neutral on Gilead Sciences, Raises Price Target to $96

Since its launch in 2018, CUPRA, the first new automotive brand created within the Volkswagen Group, has sold over 750,000 cars.&nbsp;
&nbsp;

VWAGY

Spain Car Brand CUPRA Says It Is In Preliminary Talks With Penske Automotive Group To Explore Partnership In US

This collaboration provides Inspirato members with access to BLADE's helicopter services, bringing them closer to Inspirato's luxury destinations with unmatched convenience and style.

ISPO

Inspirato Enters Strategic Partnership With BLADE  Urban Air Mobility

Editor&#8217;s note: This story has been updated to remove references to an individual that lacked context and relevance. 
Crude oil WTI futures saw a slight uptick following a significant phone call between President-elect Donald Trump and Russian President Vladimir Putin.
What Happened: At the time of writing, Crude Oil WTI Futures was up 0.18% at $70.25 per barrel on Monday during pre-market hours.
President-elect Trump reportedly had a phone discussion with President Putin on Thursday, marking their first interaction since Trump&#8217;s election win, The Washington Post <a href="https://www.washingtonpost.com/national-security/2024/11/10/trump-putin-phone-call-ukraine/">reported</a> on Sunday. Trump urged Putin to refrain from escalating the Ukraine conflict, highlighting the substantial U.S. military presence in Europe. The dialogue also included discussions on achieving peace across Europe, with Trump expressing interest in further talks to hasten a resolution to the Ukraine issue. 
These developments could have contributed to a rise in Crude Oil WTI Futures. The market often responds to potential de-escalation in geopolitical tensions, which can ease supply concerns and potentially lower prices.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41869034/skyrocketing-bitcoin-nears-80000-milestone-on-optimism-over-trump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Surges Past $80,000 Milestone For First Time On Optimism Over Trump</a>
Why It Matters: The phone call between <a href="https://www.benzinga.com/news/global/24/11/41865062/putin-congratulates-trump-on-2024-election-victory-russian-leader-said-president-elect-manly-for-how-he-handled-assassination-attempt">Trump and Putin</a> comes amid heightened scrutiny of Russian oil trade. The U.S. Justice Department has been intensifying efforts to enforce sanctions on Russia&#8217;s energy exports. 
Additionally, Russian oil has found its way to U.S. shores through a <a href="https://www.benzinga.com/news/earnings/24/02/36888966/russian-oil-hits-us-shores-under-sanction-busting-loophole">sanction-busting loophole</a>, despite a ban on its import following Russia&#8217;s invasion of Ukraine. 
Oil prices have been volatile lately, with <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41715076/oil-prices-spike-by-over-3-as-opec-delays-production-increases-ahead-of-us-electi">OPEC+ recently delaying production </a>increases ahead of the U.S. elections, causing a spike in prices.
Meanwhile, Oil prices remained relatively stable on Monday as concerns over potential supply disruptions from a U.S. storm subsided, and China's recent stimulus measures underwhelmed investors hoping for a boost in fuel demand from the world's second-largest oil consumer. Brent crude futures edged up by 4 cents, reaching $73.91 per barrel by 0714 GMT, while U.S. West Texas Intermediate (WTI) crude slipped 7 cents to $70.31 per barrel.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41868204/cryptocurrencies-rally-following-trump-victory-el-salvadors-bitcoin-bet-pays-off-and-more-top-crypto-updates-this-week?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Cryptocurrencies Rally Following Trump Victory, El Salvador&#8217;s Bitcoin Bet Pays Off And More: Top Crypto Updates This Week</a></li>
</ul>
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Photo by Evan El-Amin and Frederic Legrand &#8211; COMEO on Shutterstock

Commodities

General

Trump Reportedly Urges Russian President To Deescalate War With Ukraine: Here's How Crude Oil WTI Futures Are Reacting (UPDATED)

MicroStrategy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares are climbing after-hours after the company announced it completed its previously announced offering of its 0% convertible <a href="https://www.benzinga.com/pressreleases/24/11/b42122992/microstrategy-completes-3-000-000-000-offering-of-0-convertible-senior-notes-due-2029">senior notes due 2029.&nbsp;</a>
The Details: MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3 billion, which includes $400 million aggregate principal amount of notes issued pursuant to an option to purchase.&nbsp;
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
The net proceeds from the sale of the notes were approximately $2.97 billion, after deducting the initial purchasers&#8217; discounts and commissions and estimated offering expenses payable by the company.&nbsp;
MicroStrategy intends to use the net proceeds from the sale of the notes to acquire additional Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and for general corporate purposes. MicroStrategy holds a total of 331,200 Bitcoin purchased at an average price of approximately $49,874 per coin as of Nov. 17.
What Else: MicroStrategy shares fell more than 16% in Thursday's regular session after short-seller Citron Research's Andrew Left announced he took a new <a href="https://www.benzinga.com/24/11/42118133/short-seller-andrew-left-targets-microstrategy-stock-as-hedge-against-bullish-bitcoin-bet-completely-detached-from-btc-fundamentals">short position</a> in the stock which has rallied more than 50% since President-elect Donald Trump won the election on Nov. 5.&nbsp;
"Fast forward to today: $MSTR has skyrocketed to over $5,000 (adjusted) … while Citron remains bullish on Bitcoin, we&#8217;ve hedged with a short $MSTR position," Left said. "Much respect to @saylor, but even he must know $MSTR is overheated," Citron Research wrote in a post on X.&nbsp;
MSTR Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, MicroStrategy shares are up 5.48% after-hours at $410.05 at the time of publication Thursday.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Courtesy of MicroStrategy, Inc.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Short Sellers

After-Hours Center

$BTC

MSTR

What's Going On With MicroStrategy Stock After The Bell?

AESI

Atlas Energy Solutions To Replace Mueller Industries In S&P SmallCap 600

Mueller Industries To Replace Texas Pacific Land In S&P MidCap 400

Cannabis stocks reacted with mixed results on Thursday after Matt Gaetz <a href="https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction">withdrew his nomination</a> for U.S. Attorney General amid <a href="https://www.benzinga.com/news/legal/24/11/42078192/trumps-attorney-general-pick-matt-gaetz-resigned-from-congress-ethics-committee-to-decide-if-report-will-be-released">allegations</a> of sexual misconduct, drug use, lack of legal experience and more. Last week, President-elect Donald Trump <a href="https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general">nominated</a> Gaetz who is a long-time supporter of cannabis legalization. 
While Gaetz's exit may not be directly tied to the sector's performance, multi-state operators (MSOs) and cannabis ETFs recorded notable declines, reflecting ongoing investor jitters in a politically sensitive market.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">MSOs Slides, Sector Faces Pressure</h3>
The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. This decline highlights the continued uncertainty in the cannabis space, as investors reassess the implications of a reshuffling political landscape.
Curaleaf Holdings Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>), one of the largest MSOs in the U.S., shed -4.10%, finishing the day at $1.99. Trulieve Cannabis Corp. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) was not far behind, falling -1.93% to $6.11. Meanwhile, Cresco Labs Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTCQX">CRLBF</a>) dropped -5.74%, closing at $1.15.While some MSOs struggled, Green Thumb Industries (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>) managed to stay in positive territory closing at $9.30.
<h3 class="wp-block-heading">Sundial Stands Out</h3>
Sundial Growers Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) defied the broader sector trends, climbing 1.79% to end the day at $1.995. Other gainers included Tilray Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), which rose 1.94% to $1.315, and Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>), up 2.53% to $3.855.
<h3 class="wp-block-heading">Deep Declines&nbsp;</h3>
Thursday saw significant losses among smaller players, with Cansortium Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTCQX">CNTMF</a>) plunging -22.72%, closing at $0.0711. iAnthus Capital Holdings Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTCQX">ITHUF</a>) also struggled, dropping -11.43% to $0.00558.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/11/42122634/gop-bathroom-battle-cannabis-advocate-nancy-mace-will-stand-in-the-way-of-any-man-who-tries-to-get-into-womens-room">GOP Bathroom Battle: Cannabis Advocate Nancy Mace Will &#8216;Stand In The Way Of Any Man&#8217; Who Tries To Get Into Women&#8217;s Room</a>

Cannabis

Government

Politics

ETFs

CNTMF

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

ITHUF

MSOS

SNDL

TCNNF

TLRY

Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee

Texas Pacific Land  To Replace Marathon Oil In S&P 500

The price of leading cryptocurrency Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) continues to hit new all-time highs, breaking several records since the<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42109267/bitcoin-hits-new-all-time-high-above-98000-as-spot-etfs-crack-100-billion-net-asset-value-milestone"> 2024 presidential election.</a>
Investors who bought earlier this year or ahead of the election have generated strong profits, but nowhere near the gains that investors got being early believers in the cryptocurrency.
What Happened: In October 2008, pseudonymous&nbsp;Satoshi Nakamoto<a href="https://www.benzinga.com/markets/cryptocurrency/22/08/28349295/understanding-bitcoins-whitepaper" target="_blank" rel="noreferrer noopener">&nbsp;published a whitepaper</a>&nbsp;titled &#8220;Bitcoin: A Peer-to-Peer Electronic Cash System.&#8221; The whitepaper provided many key details and explained why Bitcoin was created.
In January 2009, Nakamoto mined the genesis block of the first 50 Bitcoins and the cryptocurrency was officially born.
When Bitcoin was released, there were only two ways to get the cryptocurrency: mine the Bitcoin yourself or use a peer-to-peer transaction.
Bitcointalk, a forum created by Nakamoto to host discussions on Bitcoin, was used for several transactions. The transactions were deemed risky at the time because they required trust from both parties and were mostly anonymous.
In October 2009, one of the first-ever recognized Bitcoin transactions happened when a Finnish computer science student sold 5,050 Bitcoin for $5.02 (which represented a value of $0.0009 for each Bitcoin), according to&nbsp;<a href="https://www.forbes.com/advisor/investing/cryptocurrency/bitcoin-price-history/" target="_blank" rel="noreferrer noopener">Forbes</a>. The transaction took place on&nbsp;PayPal.
Less than a year later in May 2010, one of the most famous Bitcoin transactions of all time — and what is widely believed to be the first retail transaction — took place when programmer&nbsp;Laszlo Hanyecz&nbsp;sought out a person to buy him pizza in exchange for Bitcoin. A person in England subsequently spent around $41 to buy pizza from Papa John&#8217;s for Hanyecz in exchange for 10,000 Bitcoin. This represented a value of around $0.0041 for each Bitcoin.
It wasn&#8217;t until 2011 and after the launch of several major crypto exchanges that the cryptocurrency hit a price of $1.
In 2021, Bitcoin&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36083106/heres-how-much-100-invested-in-bitcoin-today-will-be-worth-if-crypto-hits-new-all-time-hig" target="_blank" rel="noreferrer noopener">hit an all-time high</a>&nbsp;of $68,789.63 as part of a year that saw increased interest in the leading cryptocurrency and many other cryptocurrencies.
In 2022, Bitcoin and other cryptocurrencies fell in value and interest with several notable cryptocurrency trading platforms declaring bankruptcy.
The<a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36514679/wall-street-enters-the-crypto-age-sec-issues-historic-approval-of-spot-bitcoin-etfs" target="_blank" rel="noreferrer noopener">&nbsp;approval of Bitcoin ETFs&nbsp;</a>in 2024 has led to increased interest in Bitcoin once again and a surge in the price of the leading cryptocurrency.
Fast forward to today and Bitcoin is trading near the $100,000 milestone with a current price of $98,093.47 at the time of writing. Bitcoin hit a new all-time high of $99,014.21 earlier on Nov. 21, 2024.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36471920/happy-birthday-bitcoin-15-fun-facts-about-leading-cryptocurrency">Happy Birthday Bitcoin: 15 Fun Facts About Leading Cryptocurrency</a>
Investing $1 in Bitcoin:&nbsp;Using the early transactions referenced above, a hypothetical investment in the early days could have provided quite the return for its holder, or in this case a &#8220;hodler.&#8221;
A $1 investment in Bitcoin at the time of the first transaction on PayPal would have netted 1,111.1111 Bitcoin.&nbsp;That investment would be worth $108,992,743.36 today based on a price of $98,093.47 for Bitcoin at the time of writing.
In contrast, a $1 investment in Bitcoin at the time of the Bitcoin-pizza transaction could have bought 243.9024 Bitcoin.&nbsp;That investment would be worth $23,925,232.76 today based on the same price of $98,093.47 for Bitcoin at the time of writing.
While investing in Bitcoin today might never be worth millions of dollars in the future, the hypothetical investment illustrated the large increase in the value of the leading cryptocurrency over time. Ark Invest CEO Cathie Wood<a href="https://www.benzinga.com/general/education/24/11/42017619/heres-how-much-100-in-bitcoin-could-be-worth-in-2030-if-cathie-woods-price-target-is-reached"> has a price target </a>of $3.8 million for Bitcoin by 2030.
A fixed supply of 21 million Bitcoin could also lead to further increases in the asset&#8217;s price as more people seek to take positions.
Many have predicted Bitcoin&#8217;s death over the years, but the cryptocurrency remains the leader in the space and has a market capitalization of over $1 trillion today.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/events/24/11/42071064/exclusive-anthony-pompliano-calls-for-us-to-buy-250b-bitcoin-on-day-1-of-trump-administration-protect-our-future-its-such-a-no-brainer">EXCLUSIVE: Anthony Pompliano Calls For US To Buy $250B Bitcoin On Day 1 Of Trump Administration: &#8216;Protect Our Future, It&#8217;s Such A No Brainer&#8217;</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Image created using artificial intelligence via Midjourney.

Education

If You Bought $1 Worth Of Bitcoin At Launch, Here's How Much You'd Have Today

Jefferies analyst Omar Nokta maintains ZIM Integrated Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) with a Hold and raises the price target from $25 to $28.

Jefferies Maintains Hold on ZIM Integrated Shipping, Raises Price Target to $28

Jefferies analyst Thomas Chong maintains PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) with a Buy and lowers the price target from $181 to $171.

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Jefferies Maintains Buy on PDD Holdings, Lowers Price Target to $171

Jefferies analyst Stephanie Wissink maintains BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) with a Buy and raises the price target from $105 to $110.

Jefferies Maintains Buy on BJ's Wholesale Club, Raises Price Target to $110

Logistic Properties Of The Americas Inks A USD-Denominated Lease For 41,226 Square Feet At Parque Logístico Callao With A Third-party Logistics Provider

The award of this two-year project is expected to generate revenue for the Company of approximately $125 million. The project is set to begin January 2025 with completion expected in October 2026.&nbsp;

Contracts

North American Construction Says Mikisew North American Limited Partnership Has Secured A Heavy Civil Construction Contract From A Producer In The Oil Sands Region

Compass Point analyst Chase White downgrades MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) from Buy to Neutral and announces $25 price target.

Downgrades

MARA

Compass Point Downgrades MARA Holdings to Neutral, Announces $25 Price Target

Cryptocurrency markets are trading higher, with Bitcoin approaching $100,000, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42122387/solana-soars-10-reaches-new-all-time-high-market-cap-what-is-going-on">Solana ETF talks</a> picking up steam and <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42122141/xrp-price-up-8-what-is-going-on-with-ripple">XRP gaining</a> on Gary Gensler announcing his resignation on Donald Trump&#8216;s inauguration day.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td> $97,986</td>
<td>+3.1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td> $3,348</td>
<td>+8.7%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td> $253.64</td>
<td>+7.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3841 </td>
<td>+1.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00002454 </td>
<td>+2.2%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 8.5% and daily active addresses up by 0.4%. Transactions greater than $100,000 are up from 11,911 to 13,321 in a single day. Exchanges netflows are down by 89%.</li>
<li>Coinglass data reports 139,421 traders were liquidated in the past 24 hours for $469.70 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121936/bitcoin-boom-20-microstrategy-gains-traction-as-a-leveraged-bet-on-crypto-growth">Bitcoin Boom 2.0? MicroStrategy Gains Traction As A &#8216;Leveraged Bet&#8217; On Crypto Growth</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114875/coinbase-ceo-brian-armstrong-stands-out-as-candidate-for-donald-trumps-reported-crypto-czar-position-cardano-co-founder-says">Coinbase CEO Brian Armstrong &#8216;Stands Out&#8217; As Candidate For Donald Trump&#8217;s Reported &#8216;Crypto Czar&#8217; Position, Cardano Co-Founder Says</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42120607/gary-gensler-to-step-down-as-sec-chair-on-trumps-inauguration-day">Gary Gensler To Step Down As SEC Chair On Trump&#8217;s Inauguration Day</a></li>
<li><a href="https://www.benzinga.com/24/11/42103633/chinese-court-affirms-cryptocurrency-ownership-as-legal-as-bitcoin-breaks-97k">Chinese Judge Cites &#8216;High-Pressure Crackdown&#8217; On Speculation In Judgment Declaring Crypto Ownership Legal As Bitcoin Moves Past $97K</a></li>
<li><a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a></li>
<li><a href="Core%20Fusion%20Upgrade%20Introduces%20Dual%20Staking%20And%20Liquid%20Bitcoin%20Staking">Core Fusion Upgrade Introduces Dual Staking And Liquid Bitcoin Staking</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Optimism (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">OP</a>)</td>
<td> $2.10</td>
<td>+26.3%</td>
</tr>
<tr>
<td>Arbitrum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ARB</a>)</td>
<td> $0.79</td>
<td>+26.2%</td>
</tr>
<tr>
<td>Starknet (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">STRK</a>)</td>
<td> $0.5031</td>
<td>+18.6%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices chasing the all-time high levels, crypto trader Kaleo <a href="https://x.com/CryptoKaleo/status/1859451257615757647">tweeted</a> "Bitcoin is currently one Ethereum away from $100,000."
Benjamin Cowen explained Bitcoin is tracking the average returns of prior halving years and if this trend continues Bitcoin could reach $120,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> is currently tracking the average returns of prior halving years. If the trend continues it would put <a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> around $120k <a href="https://t.co/FFGKs9a0Jc">pic.twitter.com/FFGKs9a0Jc</a>
&mdash; Benjamin Cowen (@intocryptoverse) <a href="https://twitter.com/intocryptoverse/status/1859683231089729885?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin explained that despite BTC nearing $100,000, there is minimal hype compared to the 2020-2021 bull run. 
He highlights a lack of live streams, sensational thumbnails, and low engagement across platforms, along with muted sentiment on Google Trends.
He <a href="https://x.com/Kev_Capital_TA/status/1859678748683231451">believes</a> investors' focus on altcoins and frustration with lack of movement could be one factor while market not reaching euphoric stage could signal still far away from cycle's peak.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42116183/michael-saylor-predicted-bitcoin-to-hit-13-million-if-it-happens-it-will-entail-massive-hyperinflation-analyst-warns">Michael Saylor Predicted Bitcoin To Hit $13 Million — If It Happens, It Will Entail &#8216;Massive Hyperinflation,&#8217; Analyst Warns</a></li>
</ul>
Image: Shutterstock

$ARB

$DOGE

$ETH

$SHIB

$SOL

$STRK

Bitcoin, Ethereum, Dogecoin Prep For Early Thanksgiving: 'BTC Is Currently (Less Than) One ETH Away From $100,000,' Says Trader

It is payable on December 31, 2024, to the shareholders of record at the close of business on December 13, 2024.

Dividends

STEL

Stellar Bancorp Boosts Quarterly Cash Dividend From $0.13 To $0.14 Per Share

Denmark is poised to cement its place as a leader in <a href="https://www.benzinga.com/topic/medical-cannabis">medical cannabis</a> regulation. On November 19, Minister of the Interior and Health Sophie Løhde <a href="https://www.ism.dk/nyheder/2024/november/regeringen-vil-goere-ordning-med-medicinsk-cannabis-paa-recept-permanent">proposed</a> making the country's medical cannabis trial scheme permanent, a bold move following <a href="https://www.benzinga.com/markets/cannabis/23/10/35346758/europes-high-irish-gps-against-pot-switzerland-spain-share-data-on-cannabis-clubs-more">years of steady growth</a> in patient participation.
<h4 class="wp-block-heading">Medical Cannabis Success in Denmark</h4>
The trial scheme, introduced in 2018, aimed to provide patients with conditions such as multiple sclerosis and cancer access to medical cannabis treatments. Extended in 2021, the program is set to expire at the end of 2025. However, its success has been undeniable. Over the last three years, more than 20,000 prescriptions have been redeemed, and approximately 1,800 patients are currently benefiting from cannabis-based medicines.
Minister Løhde highlighted the program&#8217;s impact: "We see that many patients who receive medical cannabis prescriptions appear to benefit from the treatment. This includes cancer patients suffering from severe nausea after chemotherapy and people with multiple sclerosis experiencing intense pain."
<h4 class="wp-block-heading">The Road to Permanency</h4>
The government's proposal reflects its commitment to ensuring continued legal access to medical cannabis for patients. Minister Løhde emphasized the need for collaboration, stating, "We first need to hear the perspectives of the parties involved in the agreement."
On November 19, Løhde invited representatives from political groups behind the original agreement—SF, Liberal Alliance, Red-Green Alliance, Danish People&#8217;s Party, and the Alternative—to discuss the scheme's future.
<h4 class="wp-block-heading">Industry Support</h4>
Denmark's cannabis industry also welcomed the news. Thomas Skovlund Schnegelsberg, CEO of Danish MMJ producer Stenocare, expressed optimism about the proposal. "It is excellent news for patients and Stenocare that the government is now taking steps toward permanent legalization. We are confident that the future of medical cannabis treatment is in good hands," adding that "the permanent legalization will establish a clear framework for the future, offering clarity beyond December 2025 and justifying investments in new products that deliver value to both doctors and patients."
As negotiations unfold, Denmark appears ready to solidify its role as a pioneer in regulated medical cannabis, offering hope and legal options to patients across the country.
Cover image made with AI

Psychedelics

Regulations

Eurozone

Denmark Moves Toward Permanent Medical Cannabis Program

Pareto Securities analyst Eirik Haavaldsen downgrades Golden Ocean Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) from Buy to Hold and announces $12.5 price target.

GOGL

Pareto Securities Downgrades Golden Ocean Group to Hold, Announces $12.5 Price Target

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience's recent animal study reveals promising 12-week results for its DehydraTECH-li...

Lexaria Bioscience Reports Promising Weight Loss Study

Lexaria Bioscience (LEXX) received partial 12-week blood sugar results from the recently completed animal study WEIGHT-A24-1. The company said, "Le...

Lexaria announces partial 12-week blood sugar results from GLP-1 diabetes study

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has reported promising results from its diabetes animal study, revealing that ...

Lexaria Bioscience's Promising Diabetes Study Results

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk's blockbuster drug, s...

Lexaria Bioscience provides GLP-1 industry update

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience is advancing its DehydraTECH drug delivery platform to compete in the booming ...

Lexaria Bioscience Enters GLP-1 Market Race

Lexaria Bioscience (LEXX) has received lead clinical site human research ethics committee approval that was required before dosing can begin in the...

Lexaria Bioscience receives HREC approval for Phase 1b DehydraTECH GLP-1 study

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has received ethics board approval for its 12-week Phase 1b GLP-1 study, which...

Lexaria Bioscience Advances GLP-1 Study

Lexaria Bioscience (LEXX) has engaged a contract research organization to perform the world's first-ever fluorescently tagged DehydraTECH-semagluti...

Lexaria Bioscience signs contract for DehydraTECH GLP-1 biodistribution study

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has initiated a groundbreaking study to explore the biodistribution of its Deh...

Lexaria Bioscience Launches Innovative Drug Study

Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience's DehydraTECH technology has shown promising results in a 12-week diabetes ani...

Lexaria Bioscience's DehydraTECH Outshines in Diabetes Study

Press Releases

Lexaria Updates Current GLP-1 Market

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing

Offerings

Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study

Comments

Lexaria Bioscience

Lexaria Bioscience (LEXX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga